相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Impact of bladder neck involvement on progression in patients with primary non-muscle invasive bladder cancer: A prospective validation study
Shuichiro Kobayashi et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2014)
Incidence and location of lymph node metastases in patients undergoing radical cystectomy for clinical non muscle invasive bladder cancer: Results from a prospective lymph node mapping study
Harman M. Bruins et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2014)
Ubiquitin-like (UBX)-domain-containing protein, UBXN2A, promotes cell death by interfering with the p53-Mortalin interactions in colon cancer cells
S. Sane et al.
CELL DEATH & DISEASE (2014)
Essential role of autophagy in fucoxanthin-induced cytotoxicity to human epithelial cervical cancer HeLa cells
Li-li Hou et al.
ACTA PHARMACOLOGICA SINICA (2013)
Molecular interactions of Bcl-2 and Bcl-xL with mortalin: identification and functional characterization
Nishant Saxena et al.
BIOSCIENCE REPORTS (2013)
Cancer statistics, 2013
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2013)
Current intravesical therapy for non-muscle invasive bladder cancer
Anna V. van Lingen et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2013)
Quality of life in patients with muscle invasive and non-muscle invasive bladder cancer
S. Singer et al.
SUPPORTIVE CARE IN CANCER (2013)
Isolation of fucoxanthin from edible brown algae by microwave-assisted extraction coupled with high-speed countercurrent chromatography
Xiaohua Xiao et al.
JOURNAL OF SEPARATION SCIENCE (2012)
Fucoxanthin Attenuates Rifampin-Induced Cytochrome P450 3A4 (CYP3A4) and Multiple Drug Resistance 1 (MDR1) Gene Expression Through Pregnane X Receptor (PXR)-Mediated Pathways in Human Hepatoma HepG2 and Colon Adenocarcinoma LS174T Cells
Cheng-Ling Liu et al.
MARINE DRUGS (2012)
Prognostic Factors for Upper Urinary Tract Urothelial Carcinoma after Nephroureterectomy
Kenji Kuroda et al.
UROLOGIA INTERNATIONALIS (2012)
In silico study of fucoxanthin as a tumor cytotoxic agent
Hedi I. Januar et al.
JOURNAL OF PHARMACY AND BIOALLIED SCIENCES (2012)
Fucoxanthin and its deacetylated product, fucoxanthinol, induce apoptosis of primary effusion lymphomas
Kei Yamamoto et al.
CANCER LETTERS (2011)
Inhibition of Smad3 activity by cyclin D-CDK4 and cyclin E-CDK2 in breast cancer cells
Fang Liu
CELL CYCLE (2011)
Mortalin-p53 interaction in cancer cells is stress dependent and constitutes a selective target for cancer therapy
W-J Lu et al.
CELL DEATH AND DIFFERENTIATION (2011)
Induction of mutant p53-dependent apoptosis in human hepatocellular carcinoma by targeting stress protein mortalin
Wen-Jing Lu et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Bacterial Reverse Mutation Test and Micronucleus Test of Fucoxanthin Oil from Microalgae
Kumiko Iio et al.
FOOD HYGIENE AND SAFETY SCIENCE (2011)
Prognostic factors for upper urinary tract urothelial carcinoma
Thomas F. Chromecki et al.
NATURE REVIEWS UROLOGY (2011)
Fucoxanthin Induces Apoptosis in Osteoclast-like Cells Differentiated from RAW264.7 Cells
Swadesh K. Das et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2010)
Keto-Carotenoids Are the Major Metabolites of Dietary Lutein and Fucoxanthin in Mouse Tissues
Lina Yonekura et al.
JOURNAL OF NUTRITION (2010)
Fucoxanthin induces apoptosis in human leukemia HL-60 cells through a ROS-mediated Bcl-xL pathway
Kil-Nam Kim et al.
TOXICOLOGY IN VITRO (2010)
Inhibition of proliferation of a hepatoma cell line by fucoxanthin in relation to cell cycle arrest and enhanced gap junctional intercellular communication
Cheng-Ling Liu et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2009)
Single and repeated oral dose toxicity study of fucoxanthin (FX), a marine carotenoid, in mice
Fumiaki Beppu et al.
JOURNAL OF TOXICOLOGICAL SCIENCES (2009)
miR-34a, miR-29c and miR-17-5p are downregulated in CLL patients with TP53 abnormalities
M. Mraz et al.
LEUKEMIA (2009)
NORSOLORINIC ACID INHIBITS PROLIFERATION OF T24 HUMAN BLADDER CANCER CELLS BY ARRESTING THE CELL CYCLE AT THE G0/G1 PHASE AND INDUCING A FAS/MEMBRANE-BOUND FAS LIGAND-MEDIATED APOPTOTIC PATHWAY
Clay C. C. Wang et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2008)
Antiadult T-cell leukemia effects of brown algae fucoxanthin and its deacetylated product, fucoxanthinol
Chie Ishikawa et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Prognostic value of MET, RON and histoprognostic factors for urothelial carcinoma in the upper urinary tract
E. Comperat et al.
JOURNAL OF UROLOGY (2008)
Mutant p53: an oncogenic transcription factor
S. Strano et al.
ONCOGENE (2007)
Three faces of mortalin: A housekeeper, guardian and killer
Sunil C. Kaul et al.
EXPERIMENTAL GERONTOLOGY (2007)
Fucoxanthin induces cell cycle arrest at G0/G1 phase in human colon carcinoma cells through up-regulation of p21WAF1/Cip1
SK Das et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2005)
Identification and characterization of molecular interactions between mortalin/mtHsp70 and HSP60
R Wadhwa et al.
BIOCHEMICAL JOURNAL (2005)
Neoxanthin and fucoxanthin induce apoptosis in PC-3 human prostate cancer cells
E Kotake-Nara et al.
CANCER LETTERS (2005)
Understanding and modulating cyclin-dependent kinase inhibitor specificity: molecular modeling and biochemical evaluation of pyrazolopyrimidinones as CDK2/cyclin A and CDK4/cyclin D1 inhibitors
KA Rossi et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2005)
Fucoxanthin induces apoptosis and enhances the antiproliferative effect of the PPARγ ligand, troglitazone, on colon cancer cells
M Hosokawa et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2004)
Does p53 affect organismal aging?
LA Donehower
JOURNAL OF CELLULAR PHYSIOLOGY (2002)
Death signal-induced localization of p53 protein to mitochondria - A potential role in apoptotic signaling
ND Marchenko et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
分享论文
